Evaluation of BMP-2 tethered polyelectrolyte coatings on hydroxyapatite scaffolds in vivo

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 7, 2012, Pages 1782-1791

  Shiels, Stefanie ^a,b   Oh, Sunho ^a   Bae, Chunsik ^e   Guda, Teja ^a   Singleton, Brian ^a,b   Dean, David D ^b,c   Wenke, Joseph C ^d   Appleford, Mark R ^a,b   Ong, Joo L ^a,b  

^a The University of Texas at San Antonio   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d U S ARMY   (United States)

^e Chonnam National University   (South Korea)

Author keywords

bone; in vivo; polyelectrolyte; rhBMP 2; scaffolds

Indexed keywords

BONE GRAFT; BONE INDUCTION; BONE REGENERATION; DRUG LOADING; FEMORAL CONDYLES; FOUR-GROUP; HISTOMORPHOMETRY; IN-VIVO; INTERCONNECTIVITY; MICRO CT; NEGATIVE CONTROL; NEW ZEALAND WHITE RABBIT; NON-LOAD BEARINGS; POROUS HYDROXYAPATITE; PYCNOMETRY; RECOMBINANT BONE MORPHOGENETIC PROTEIN-2; RHBMP-2; TISSUE GROWTH; TISSUE INTERACTIONS; VASCULARIZATION;

BONE; COATINGS; COMPUTERIZED TOMOGRAPHY; HYDROXYAPATITE; LOADING; POLYELECTROLYTES; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY; TISSUE;

SCAFFOLDS (BIOLOGY);

HYDROXYAPATITE; POLYELECTROLYTE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ARTICLE; BONE GRAFT; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; ILIAC CREST; IN VIVO STUDY; MORPHOMETRICS; NONHUMAN; POROSITY; SCANNING ELECTRON MICROSCOPY; TISSUE GROWTH;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONE SUBSTITUTES; COATED MATERIALS, BIOCOMPATIBLE; DURAPATITE; FEMUR; HUMANS; MATERIALS TESTING; RABBITS; RECOMBINANT PROTEINS; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84865977165     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32745     Document Type: Article

References (34)

1. Bauer T, Muschler G,. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000; 371: 10-27.
2. Lee S, Shin H,. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Delivery Rev 2007; 59: 339-359.
3. Zimmermann G, Moghaddam A,. Allograft bone matrix versus synthetic bone graft substitute. Injury, Int J Care Injured 2011; 42: S16-S21.
4. Sasso R, LeHuec J, Shaffrey C,. Ilicac crest bone graft donor site pain after anterior lumbar interbody fusion: A prospective patient satisfaction outcome assessment. J Spinal Disord Tech 2005; 18 Supp: S77-S81.
5. Young R,. Biological Apatite versus hydroxyapatite at the atomic level. Clin Orthop Relat Res 1975; 113: 249-262.
6. Appleford M, Oh S, Oh N, Ong J,. In vivo study on hydroxyapatite scaffolds with trabecular architecture for bone repair. J Biomed Mater Res 2009; 89: 1019-1027.
7. Si X, Yang L, Jin Y,. Induction of osteogenic potential of fibroblasts by transfection of rhBMP-2. In:, Lindholm T, editor. Advances in Skeletal Reconstruction Using Bone Morphogenetic Proteins. Singapore: World Scientific Publishing; 2002. pp 19-34.
8. Bessa P, Casal M, Reis R,. Bone Morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008; 2: 1-13.
9. Wang EA, Rosen V, Dalessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, Lapan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM,. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990; 87: 2220-2224.
10. Wozney J, Rosen V,. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998; 346: 26-37.
11. Murakami N, Saita N, Takahashi J, Ota H, Horiuchi H, Nawata M, Okada T, Nozaki K, Takaoka K,. Repair of a proximal femoral bone defect in dogs using a porous surface prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 2003; 24: 2153-2159.
12. Seeherman H, Bouxsein M, Kim H, Li R, Li X, Aiolova M, Wozney J,. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J Bone Joint Surg Am A 2004; 86: 1961-1972.
13. Medtronic(R) INFUSE Bone Graft + LT-Cage (R) Lumbar Tapered Fusion Device Fact Sheet.
14. Dai K, Xu X, Tang T, Zhu Z, Yu C, Lou J, Zhang X,. Repairing of goat tibial defects with BMP-2 gene-modified tissue engineered bone. Calc Tissue Int 2005; 77: 55-61.
15. Degat M, Dubreucq G, Meunier A, Dahri-Correia L, Sedel L, Petite H, Logeart-Avramoglou D,. Enhancement of the biological activity of BMP-2 by synthetic dextran derivatives. J Biomed Mater Res A 2008; 88: 174-183.
16. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H, Fujimura S,. Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 1997; 60: 291-296.
17. Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, Li W, Chiang M, Chung J, Kwak J, Wu BM, Ting K, Soo C,. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng: Part A 2011; 17 (9 and 10): 1389-1399.
18. Shields L, Raque G, Glassman S, Campbell M, Vitaz T, Harpring J, Shields C,. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006; 31: 542-547.
19. Schultz D,. FDA Public Health Notification: Life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion: U.S. Food and Drug Administration; 2008.
20. Bessa P, Casal M, Reis R,. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP Delivery). J Tissue Eng Regen Med 2008; 2: 81-96.
21. Liu H, Chen C, Tsai C, Lin I, Hsiue G,. Heterobifunctional Poly(ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. Tissue Eng 2007; 13: 1113-1124.
22. Vaibhav B, Nilesh P, Vikram S, Anshul C,. Bone morphogenetic protein and it's application in trauma cases: A current concept update. Injury, Int J Care Injured 2007; 38: 1227-1235.
23. Zhang S, Wright J, Ozber N, Uludag H,. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite. Macromol Biosci 2007; 7: 656-670.
24. Hutmacher D,. Scaffold design and fabrication technologies for engineering tissues-State of the art and future perspectives. J Biomaterials Sci Poly Ed 2001; 12: 107-124.
25. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P,. Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest, and calcaneous. J Bone Mineral Res 1999; 14: 1167-1174.
26. Bates B, Guda T, Hernandez J, Singleton B, Appleford M, Oh S, Ong J,. Changes in trabecular-like hydroxyapatite scaffold permeability after in vitro cell culture. The Society for Biomaterials Annual Meeting, San Antonio, TX 2009.
27. Schuessele A, Mayr H, Tessmar J, Goepferich. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J Biomed Mater Res A 2009; 90: 959-971.
28. Dong X, Wang Q, Wu T, Pan H,. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 2007; 93: 750-759.
29. Castellani C, Zanoni G, Tangl S, van Griensven M, Redl H,. Biphasic calcium phosphate ceramics in small bone defects: Potential influence of carrier substances and bone marrow on bone regeneration. Clin Oral Impl Res 2009; 20: 1367-1374.
30. Lu J, Gallur A, Flautre B, Anselme K, Descamps M, Thierry B, Hardouin P,. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites. J Biomed Mater Res 1998; 42: 357-367.
31. Liu L, Morgan E,. Accuracy and precision of digital volume correlation in quantifying displacements and strains in trabecular bone. J Biomech 2007; 40: 3516-3520.
32. Frisch S, Vuori K, Rouslahti E, Chan-Hui P,. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Bio 1996; 134: 793-799.
33. Luginbuehl V, Meinel L, Merkle H, Gander B,. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004; 58: 197-208.
34. Traut RR, Bollen A, Sun TT, Hershey JW, Sundberg J, Pierce LR,. Methyl-4-mercaptobutyrimidate as a cleavable crosslinking reagent and its application to escherichia-coli 30S ribosome. Biochemistry 1973; 12: 3266-3273.